THYROID CYTOPATHOLOGY PARTNERS Trademark

Trademark Overview


On Tuesday, October 14, 2014, a trademark application was filed for THYROID CYTOPATHOLOGY PARTNERS with the United States Patent and Trademark Office. The USPTO has given the THYROID CYTOPATHOLOGY PARTNERS trademark a serial number of 86422930. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, November 17, 2021. This trademark is owned by Thyroid Cytopathology Partners, P.A.. The THYROID CYTOPATHOLOGY PARTNERS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services; medical services in the fields of pathology and cytopathology; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; medical consultation services
thyroid cytopathology partners

General Information


Serial Number86422930
Word MarkTHYROID CYTOPATHOLOGY PARTNERS
Filing DateTuesday, October 14, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, November 17, 2021
Registration Number4980679
Registration DateTuesday, June 21, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements


Goods and ServicesMedical services; medical services in the fields of pathology and cytopathology; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; medical consultation services
NOT AVAILABLE"PARTNERS"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 20, 2014
Primary Code044
First Use Anywhere DateTuesday, November 30, 2010
First Use In Commerce DateTuesday, November 30, 2010

Trademark Owner History


Party NameThyroid Cytopathology Partners, P.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAustin, TX 78727

Party NameThyroid Cytopathology Partners, P.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAustin, TX 78727

Party NameThyroid Cytopathology Partners, P.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAustin, TX 78727

Trademark Events


Event DateEvent Description
Monday, October 20, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 3, 2015ASSIGNED TO EXAMINER
Tuesday, February 3, 2015NON-FINAL ACTION WRITTEN
Tuesday, February 3, 2015NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 3, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 20, 2015FINAL REFUSAL WRITTEN
Thursday, August 20, 2015FINAL REFUSAL E-MAILED
Thursday, August 20, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 18, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, February 18, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016REGISTERED-PRINCIPAL REGISTER
Monday, June 21, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 17, 2014NEW APPLICATION ENTERED
Monday, February 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 13, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, November 17, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 17, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, June 21, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, November 17, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED